Disease-Specific α-Synuclein Seeding in Lewy Body Disease and Multiple System Atrophy Are Preserved in Formaldehyde-Fixed Paraffin-Embedded Human Brain

Biomolecules. 2023 Jun 2;13(6):936. doi: 10.3390/biom13060936.

Abstract

Recent studies have been able to detect α-synuclein (αSyn) seeding in formaldehyde-fixed paraffin-embedded (FFPE) tissues from patients with synucleinopathies using seed amplification assays (SAAs), but with relatively low sensitivity due to limited protein extraction efficiency. With the aim of introducing an alternative option to frozen tissues, we developed a streamlined protein extraction protocol for evaluating disease-specific seeding in FFPE human brain. We evaluated the protein extraction efficiency of different tissue preparations, deparaffinizations, and protein extraction buffers using formaldehyde-fixed and FFPE tissue of a single Lewy body disease (LBD) subject. Alternatively, we incorporated heat-induced antigen retrieval and dissociation using a commercially available kit. Our novel protein extraction protocol has been optimized to work with 10 sections of 4.5-µm-thickness or 2-mm-diameter micro-punch of FFPE tissue that can be used to seed SAAs. We demonstrated that extracted proteins from FFPE still preserve seeding potential and further show disease-specific seeding in LBD and multiple system atrophy. To the best of our knowledge, our study is the first to recapitulate disease-specific αSyn seeding behaviour in FFPE human brain. Our findings open new perspectives in re-evaluating archived human brain tissue, extending the disease-specific seeding assays to larger cohorts to facilitate molecular subtyping of synucleinopathies.

Keywords: FFPE; SAA; alpha-synuclein; protein extraction; seeding behaviour.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Brain / metabolism
  • Formaldehyde
  • Humans
  • Lewy Body Disease*
  • Multiple System Atrophy*
  • Paraffin
  • Paraffin Embedding / methods
  • Synucleinopathies*
  • alpha-Synuclein / metabolism

Substances

  • alpha-Synuclein
  • Paraffin
  • Formaldehyde

Grants and funding

This study was supported by the Edmond J Safra Philanthropic Foundation, the Krembil Foundation, the Maybank Foundation, and the Rossy Foundation. A.K. is supported by the Centre for Research in Neurodegenerative Disease (CRND) Graduate Student Endowment, Unilever/Lipton Graduate Fellowship Award in Neurosciences, and the Jesse Keshin Graduate Student Award. The funding bodies did not take part in the design of the study, in collection, analysis, or interpretation of data, or in writing the manuscript.